Lisa Q Rong, Grant Luhmann, Antonino Di Franco, Arnaldo Dimagli, Luke A Perry, Andrew P Martinez, Michelle Demetres, C David Mazer, Rinaldo Bellomo, Mario Gaudino
{"title":"心脏手术中肺动脉导管的使用与院内预后:系统综述与元分析》。","authors":"Lisa Q Rong, Grant Luhmann, Antonino Di Franco, Arnaldo Dimagli, Luke A Perry, Andrew P Martinez, Michelle Demetres, C David Mazer, Rinaldo Bellomo, Mario Gaudino","doi":"10.1093/icvts/ivae129","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To determine the association of intraoperative pulmonary artery catheter (PAC) use with in-hospital outcomes in cardiac surgical patients.</p><p><strong>Methods: </strong>MEDLINE, Embase, and Cochrane Library (Wiley) databases were screened for studies that compared cardiac surgical patients receiving intraoperative PAC with controls and reporting in-hospital mortality. Secondary outcomes included intensive care unit length of stay, cost of hospitalization, fluid volume administered, intubation time, inotropes use, acute kidney injury (AKI), stroke, myocardial infarction (MI), and infections.</p><p><strong>Results: </strong>Seven studies (25 853 patients, 88.6% undergoing coronary artery bypass graft surgery) were included. In-hospital mortality was significantly increased with PAC use [odds ratio (OR) 1.57; 95% confidence interval (CI) 1.12-2.20, P = 0.04]; PAC use was also associated with greater intraoperative inotrope use (OR 2.61; 95% CI 1.54-4.41) and costs [standardized mean difference (SMD) = 0.20; 95% CI 0.16-0.23], longer intensive care unit stay (SMD = 0.29; 95% CI 0.25-0.33), and longer intubation time (SMD = 0.44; 95% CI 0.12-0.76).</p><p><strong>Conclusions: </strong>PAC use is associated with significantly increased odds of in-hospital mortality, but the amount and quality of the available evidence is limited. Prospective randomized trials testing the effect of PAC on the outcomes of cardiac surgical patients are urgently needed.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254303/pdf/","citationCount":"0","resultStr":"{\"title\":\"Pulmonary artery catheter use and in-hospital outcomes in cardiac surgery: a systematic review and meta-analysis.\",\"authors\":\"Lisa Q Rong, Grant Luhmann, Antonino Di Franco, Arnaldo Dimagli, Luke A Perry, Andrew P Martinez, Michelle Demetres, C David Mazer, Rinaldo Bellomo, Mario Gaudino\",\"doi\":\"10.1093/icvts/ivae129\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>To determine the association of intraoperative pulmonary artery catheter (PAC) use with in-hospital outcomes in cardiac surgical patients.</p><p><strong>Methods: </strong>MEDLINE, Embase, and Cochrane Library (Wiley) databases were screened for studies that compared cardiac surgical patients receiving intraoperative PAC with controls and reporting in-hospital mortality. Secondary outcomes included intensive care unit length of stay, cost of hospitalization, fluid volume administered, intubation time, inotropes use, acute kidney injury (AKI), stroke, myocardial infarction (MI), and infections.</p><p><strong>Results: </strong>Seven studies (25 853 patients, 88.6% undergoing coronary artery bypass graft surgery) were included. In-hospital mortality was significantly increased with PAC use [odds ratio (OR) 1.57; 95% confidence interval (CI) 1.12-2.20, P = 0.04]; PAC use was also associated with greater intraoperative inotrope use (OR 2.61; 95% CI 1.54-4.41) and costs [standardized mean difference (SMD) = 0.20; 95% CI 0.16-0.23], longer intensive care unit stay (SMD = 0.29; 95% CI 0.25-0.33), and longer intubation time (SMD = 0.44; 95% CI 0.12-0.76).</p><p><strong>Conclusions: </strong>PAC use is associated with significantly increased odds of in-hospital mortality, but the amount and quality of the available evidence is limited. Prospective randomized trials testing the effect of PAC on the outcomes of cardiac surgical patients are urgently needed.</p>\",\"PeriodicalId\":73406,\"journal\":{\"name\":\"Interdisciplinary cardiovascular and thoracic surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254303/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Interdisciplinary cardiovascular and thoracic surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/icvts/ivae129\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"0\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interdisciplinary cardiovascular and thoracic surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/icvts/ivae129","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"0","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
目的确定心脏手术患者术中使用肺动脉导管(PAC)与院内预后的关系:筛选了MEDLINE、Embase和Cochrane Library (Wiley)数据库中将接受术中肺动脉导管的心脏外科患者与对照组进行比较并报告院内死亡率的研究。次要结果包括重症监护室(ICU)住院时间、住院费用、输液量、插管时间、肌注药物使用、急性肾损伤(AKI)、中风、心肌梗死(MI)和感染:共纳入七项研究(25853 名患者,88.6% 接受冠状动脉旁路移植手术)。使用 PAC 会明显增加院内死亡率(OR 1.57;95% CI 1.12-2.20,P = 0.04);使用 PAC 还与术中使用更多肌力药物有关(OR 2.61;95% CI 1.54-4.41)和费用(SMD = 0.20;95% CI 0.16-0.23)、更长的 ICU 留观时间(SMD = 0.29;95% CI 0.25-0.33)和更长的插管时间(SMD = 0.44;95% CI 0.12-0.76)相关:结论:使用 PAC 与院内死亡率显著增加有关,但现有证据的数量和质量有限。目前急需进行前瞻性随机试验,检验 PAC 对心脏手术患者预后的影响。
Pulmonary artery catheter use and in-hospital outcomes in cardiac surgery: a systematic review and meta-analysis.
Objectives: To determine the association of intraoperative pulmonary artery catheter (PAC) use with in-hospital outcomes in cardiac surgical patients.
Methods: MEDLINE, Embase, and Cochrane Library (Wiley) databases were screened for studies that compared cardiac surgical patients receiving intraoperative PAC with controls and reporting in-hospital mortality. Secondary outcomes included intensive care unit length of stay, cost of hospitalization, fluid volume administered, intubation time, inotropes use, acute kidney injury (AKI), stroke, myocardial infarction (MI), and infections.
Results: Seven studies (25 853 patients, 88.6% undergoing coronary artery bypass graft surgery) were included. In-hospital mortality was significantly increased with PAC use [odds ratio (OR) 1.57; 95% confidence interval (CI) 1.12-2.20, P = 0.04]; PAC use was also associated with greater intraoperative inotrope use (OR 2.61; 95% CI 1.54-4.41) and costs [standardized mean difference (SMD) = 0.20; 95% CI 0.16-0.23], longer intensive care unit stay (SMD = 0.29; 95% CI 0.25-0.33), and longer intubation time (SMD = 0.44; 95% CI 0.12-0.76).
Conclusions: PAC use is associated with significantly increased odds of in-hospital mortality, but the amount and quality of the available evidence is limited. Prospective randomized trials testing the effect of PAC on the outcomes of cardiac surgical patients are urgently needed.